MMRF PRESS RELEASES
Multiple Myeloma Research Foundation (MMRF) Welcomes MasterCard President Chris McWilton to Board of Directors
Hoda Kotb, Carl Quintanilla Join Honorary Board of Directors
Norwalk, Connecticut — March 26, 2010
The Multiple Myeloma Research Foundation (MMRF) today announced that Chris McWilton, President of U.S. Markets for MasterCard Worldwide, has joined its Board of Directors. The MMRF also announced that Emmy-Award winners Hoda Kotb and Carl Quintanilla have joined its Honorary Board of Directors.
“Chris McWilton brings incredible expertise in finance and business strategy to the Foundation, and we enthusiastically welcome him aboard,” said Kathy Giusti, Founder and CEO of the MMRF. “We are also delighted to welcome both Hoda Kotb and Carl Quintanilla, who have shown so much passion and commitment in supporting our mission and the patients for whom we urgently work.
As President of U.S. Markets, Mr. McWilton oversees all of MasterCard's U.S. activities, including sales, business development, business strategy, and relationship management. Mr. McWilton joined MasterCard in 2003 as Corporate Controller. He also served as Chief Financial Officer and, later, President of Global Accounts, before being appointed to his current position in 2009.
Kotb is co-host of the fourth hour of NBC’s “The Today Show.” A breast cancer survivor, Kotb was honored with the Spirit of Hope Award at the MMRF’s 2009 Fall Gala for her commitment to increasing cancer awareness. The MMRF Spirit of Hope Award is awarded annually to individuals who inspire hope with their perseverance in overcoming personal obstacles such as a cancer diagnosis.
Quintanilla is co-anchor of CNBC’s “Squawk-Box”. In 2008, Quintanilla anchored CNBC’s original documentary, “The Money Chase: Inside Harvard Business School.” The prominent inclusion of Kathy Giusti, the MMRF’s Founder and CEO, has been influential in raising awareness of the disease and the Foundation’s mission.
About Multiple Myeloma
Multiple myeloma is an incurable blood cancer. The five-year relative survival rate for multiple myeloma is approximately 34 percent, one of the lowest of all cancers. In 2009, approximately 20,000 adults in the United States were diagnosed with multiple myeloma and approximately 11,000 people died from the disease.
About the Multiple Myeloma Research Foundation (MMRF)
The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)3 non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's diagnosis with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. As the world's number-one private funder of multiple myeloma research, the MMRF has raised over $130 million since its inception to fund nearly 120 laboratories worldwide. An outstanding 93% of funds raised go toward research and related programming. The MMRF has supported 40 new compounds and approaches in clinical trials and pre-clinical studies and has facilitated 24 clinical trials through its sister organization, the Multiple Myeloma Research Consortium (MMRC). For more information about the MMRF, please visit www.themmrf.org.